A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
Therapeutic Advances in Childhood Leukemia Consortium
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Kentucky